Antimicrobial Susceptibility Testing Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026 Antimicrobial susceptibility testing (AST) confirms susceptibility, detects resistance, and guides the selection of patient therapy. The tests can guide the physician in drug choice and dosage for difficult-to-treat infections. Antibiotic resistance is a major global health concern which requires action across the globe. It is increased due to antibiotic misuse and has become a major global health concern. Current methods for antimicrobial susceptibility testing (AST) used to probe for resistant or nonresistant (susceptible) phenotypes of pathogens, typically requires between two days to one week from the time of sample collection. Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2449 Market Dynamics Emergence of multidrug resistance, globally is impeding the ability to treat common infectious diseases, thereby resulting in prolonged illness, disability, and death. This is expected to increase the adoption of antimicrobial susceptibility testing during the forecast period. Moreover, the healthcare cost for patients with resistant infections is higher as compared to patients with non-resistant infections, owing to longer duration of illness, additional tests, and use of more expensive drugs. For instance, according to the World Health Organization (WHO), in 2016, around 490,000 people developed multi-drug resistant TB globally. Also, drug resistance is a major restraining factor for manufacturers that are focusing on developing drugs for HIV and malaria. Report includes chapters which deeply display the following deliverable about industry : • Antimicrobial Susceptibility Testing Market Research Objective and Assumption • Antimicrobial Susceptibility Testing Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Antimicrobial Susceptibility Testing Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Antimicrobial Susceptibility Testing Market, By Regions • Antimicrobial Susceptibility Testing Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Antimicrobial Susceptibility Testing Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Antimicrobial Susceptibility Testing Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Antimicrobial Susceptibility Testing Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Emergence of Multidrug Resistance Worldwide Is Expected To Drive the Antimicrobial Susceptibility Testing Market Revenue Resistance among various microbial species to different antimicrobial drugs have emerged as a major cause of public health threat. According to World Health Organization (WHO), these resistant microorganisms such as bacteria, fungi, viruses, and parasites are able to combat attack by antimicrobial drugs, which leads to ineffective treatment resulting in persistence and spreading of infections. Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, and others among the global population is expected to result in increasing adoption of antimicrobial susceptibility testing to reduce the resistance exposure during the forecast period. For instance, according to the WHO, in 2016, an estimated 490,000 people worldwide developed MDR-TB. The countries with the largest numbers of MDR/RR-TB cases were China, India and the Russian Federation. Moreover, development of genotypic-based methods offering rapid and accurate detection or confirmation of antimicrobial resistance is expected to drive the market growth. For instance, the Accelerate ID/AST System or ID/AST System (Accelerate) aims to reduce the turnaround time by using genetic methods. The device can identify infectious pathogens in a matter of hours instead of days, reducing diagnostic time by 30 to 50 hours. Key players operating in the global antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc. Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/market-insight/antimicrobial-susceptibility-testingmarket-2449 About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
Antimicrobial susceptibility testing (AST) confirms susceptibility, detects resistance, and guides the selection of patient therapy.
© Copyright 2024 Paperzz
